HighTower Advisors
CANC icon

HighTower Advisors’s Tema Oncology ETF CANC Stock Holding History

HighTower Advisors’s Portfolio CANC Stock Details CANC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.15M Buy
76,401
+29,160
+62% +$1.1M ﹤0.01% 1501
2026
Q1 		$1.73M Buy
+47,241
New +$1.72M ﹤0.01% 1811

Other funds holding CANC

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
PIA
Perennial Investment Advisors Los Angeles, California $1.51B AUM 28.71% 1-Year Est. Return
OIM
Oder Investment Management Woodland Hills, California $149M AUM 20.29% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
WWM
WJ Wealth Management Glendale, Arizona $253M AUM 28.6% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
RF
Roxbury Financial Mount Arlington, New Jersey $126M AUM 23.88% 1-Year Est. Return

HighTower Advisors's CANC Position: Q2 2026 in Review

HighTower Advisors increased its Tema Oncology ETF (CANC) stake by 62% in Q2 2026, buying an estimated $1.1M and bringing the position to 76,401 shares worth $3.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1501.

HighTower Advisors first reported a position in CANC in Q1 2026 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold CANC as of Q2 2026.

  • HighTower Advisors held 76,401 shares of Tema Oncology ETF worth $3.15M as of Q2 2026.
  • HighTower Advisors bought 29,160 Tema Oncology ETF shares in Q2 2026, an estimated $1.1M.
  • Tema Oncology ETF made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1501 holding.
  • HighTower Advisors first reported a position in Tema Oncology ETF in Q1 2026 and has held it in 2 quarters since.
  • 15 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.